Last 11,700 KRW
Change Today +200.00 / 1.74%
Volume 63.7K
003220 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:26 AM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daewon pharmaceutical co ltd (003220)

Year over year, Daewon Pharmaceutical Co. Ltd. has been able to grow revenues from $134.8M USD to $155.0M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 48.34% to 47.27%. This was a driver that led to a bottom line growth from $9.4M USD to $12.0M USD.
View Income Statement In South Korean Won
Currency in
Millions of US Dollars
As of:Dec 31
2010
Press
Release

USD
Dec 31
2011
USD
Dec 31
2012
USD
Dec 31
2013
USD
4 Year
Trend
Revenues141.2135.5134.8155.0
Other Revenues--0.0----
TOTAL REVENUES141.2135.5134.8155.0
Cost of Goods Sold--61.265.273.3
GROSS PROFIT141.274.369.681.7
Selling General & Admin Expenses, Total--51.549.959.0
R&D Expenses--5.54.75.6
Depreciation & Amortization, Total--0.70.91.0
Other Operating Expenses121.63.51.01.0
OTHER OPERATING EXPENSES, TOTAL121.661.256.566.6
OPERATING INCOME19.613.113.115.2
Interest Expense---0.3-0.2-0.1
Interest and Investment Income--0.30.70.7
NET INTEREST EXPENSE--0.10.50.6
Currency Exchange Gains (Loss)--0.1-0.10.2
Other Non-Operating Income (Expenses)0.1-0.20.20.3
EBT, EXCLUDING UNUSUAL ITEMS19.713.013.716.2
Gain (Loss) on Sale of Investments---0.1-0.7-0.1
Gain (Loss) on Sale of Assets---0.10.0-0.2
Other Unusual Items, Total---0.6-0.7-0.7
EBT, INCLUDING UNUSUAL ITEMS19.712.212.215.2
Income Tax Expense8.23.22.73.3
Minority Interest in Earnings--0.2-0.10.1
Earnings from Continuing Operations11.69.09.511.9
NET INCOME11.69.29.412.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS11.69.29.412.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS11.69.29.412.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003220:KS 11,700.00 KRW +200.00

003220 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003220.
View Industry Companies
 

Industry Analysis

003220

Industry Average

Valuation 003220 Industry Range
Price/Earnings 14.5x
Price/Sales 1.2x
Price/Book 1.6x
Price/Cash Flow 14.3x
TEV/Sales 1.0x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEWON PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.